Ionis Pharmaceuticals (IONS) Non-cash Items (2011 - 2026)

Ionis Pharmaceuticals' Non-cash Items history runs 16 years deep, the most recent figure standing at $69.5 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 33.91% year-over-year to $69.5 million; the TTM figure through Mar 2026 stood at $69.5 million (up 33.91% YoY), while the FY2025 annual figure was $700000.0, down 93.06% from the prior year.
• Non-cash Items was $69.5 million for Q1 2026 at Ionis Pharmaceuticals, up from $700000.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $71.1 million in Q1 2024 to a low of $100000.0 in Q4 2023.
• Historically, Non-cash Items has averaged $45.1 million across 5 years, with a median of $50.9 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items tumbled 99.76% in 2023, then soared 9989.0% in 2024.
• A 5-year view of Non-cash Items shows it stood at $41.1 million in 2022, then sank by 99.76% to $100000.0 in 2023, then jumped by 9989.0% to $10.1 million in 2024, then tumbled by 93.06% to $700000.0 in 2025, then surged by 9828.57% to $69.5 million in 2026.
• The last three Non-cash Items figures came in at $69.5 million (Q1 2026), $700000.0 (Q4 2025), and $37.2 million (Q3 2025), per Business Quant data.